Page 43 - 南京医科大学自然版
P. 43

第46卷第7期       李天天,梁晓静,乙红艳,等. 帕金森病患者血浆神经病理性蛋白及炎症因子与便秘的相关性[J].
                  2026年7月                     南京医科大学学报(自然科学版),2026,46(7):983-990                        ·989 ·


                   作者贡献声明:                                             681-685
                   李天天负责课题设计、数据收集、数据整理、统计分析、                     [9] CARLSEN H,PAJARI A M. Dietary fiber ⁃ a scoping
                论文撰写与修改;梁晓静、乙红艳、许富贵负责数据收集、量                            review for Nordic nutrition recommendations 2023[J].
                表评估、统计分析;王丽君、欧洲负责研究指导、论文指导;佟                           Food Nutr Res,2023,67:1-14
                强负责课题设计、研究指导、论文修改、经费支持。                          [10]QUIGLEY E M M. Constipation in Parkinson’s disease[J].
                   Author’s Contributions:                             Semin Neurol,2023,43(4):562-571
                   LI Tiantian was responsible for study design,data  [11]OU Z,ZHOU Y Z,WANG L J,et al. NLRP3 inflamma⁃
                collection,data organization,statistical analysis,manuscript  some inhibition prevents α⁃synuclein pathology by reliev⁃
                writing and revision. LIANG Xiaojing,YI Hongyan,and XU  ing autophagy dysfunction in chronic MPTP ⁃ treated
                Fugui were responsible for data collection,scale assessment,  NLRP3 knockout mice[J]. Mol Neurobiol,2021,58(4):
                and statistical analysis. WANG Lijun and OU Zhou were  1303-1311
                responsible for study supervision and manuscript guidance.  [12]FAN Z,PAN Y T,ZHANG Z Y,et al. Systemic activation
                TONG Qiang was responsible for study design, study     of NLRP3 inflammasome and plasma α⁃synuclein levels
                supervision,manuscript revision,and funding support.   are correlated with motor severity and progression in
               [参考文献]                                                  Parkinson’s disease[J]. J Neuroinflammation,2020,17
                                                                      (1):11
               [1] ARAÚJO B,CARIDADE⁃SILVA R,SOARES⁃GUEDES
                                                                 [13]HAN Q Q,LE W D. NLRP3 inflammasome⁃mediated neu⁃
                    C,et al. Neuroinflammation and Parkinson’s disease ⁃
                                                                       roinflammation and related mitochondrial impairment in
                    from neurodegeneration to therapeutic opportunities[J].
                                                                       Parkinson’s disease[J]. Neurosci Bull,2023,39(5):
                    Cells,2022,11(18):2908
                                                                       832-844
               [2] TANSEY M G,WALLINGS R L,HOUSER M C,et al.
                                                                 [14]SAAD H M,ATEF E,ELSAYED A E. New insights on
                    Inflammation and immune dysfunction in Parkinson
                                                                       the potential role of pyroptosis in Parkinson’s neuropa⁃
                    disease[J]. Nat Rev Immunol,2022,22(11):657-673
                                                                       thology and therapeutic targeting of NLRP3 inflamma⁃
               [3] DEVOS D,LEBOUVIER T,LARDEUX B,et al. Colonic
                                                                       some with recent advances in nanoparticle⁃based miRNA
                    inflammation in Parkinson’s disease[J]. Neurobiol Dis,
                                                                       therapeutics[J]. Mol Neurobiol,2025,62(7):9365-9384
                    2013,50:42-48
                                                                 [15]GLEESON T A,KAISER C,LAWRENCE C B,et al. The
               [4] 李    奇,秦亚娟,唐立钧. 帕金森病标志物α⁃突触核蛋
                                                                       NLRP3 inflammasome is essential for IL⁃18 production in
                    白聚集抑制剂的研究进展[J]. 南京医科大学学报(自
                                                                       a murine model of macrophage activation syndrome[J].
                    然科学版),2025,45(3):404-417
                                                                       Dis Model Mech,2024,17(7):dmm050762
                    LI Q,QIN Y J,TANG L J. Research progress on inhibitors
                                                                 [16]KAMINSKY L W,AL⁃SADI R,MA T Y. IL⁃1β and the in⁃
                    of α ⁃ synuclein aggregation,a marker for Parkinson’s
                                                                       testinal epithelial tight junction barrier[J]. Front Immu⁃
                    disease[J]. Journal of Nanjing Medical University(Natural
                                                                       nol,2021,12:767456
                    Sciences),2025,45(3):404-417
                                                                 [17]DOCSA T,SIPOS A,COX C S,et al. The role of inflamma⁃
               [5] DMAGALHÃES J,CANDEIAS E,MELO⁃MARQUES I,
                                                                       tory mediators in the development of gastrointestinal mo⁃
                    et al. Intestinal infection triggers mitochondria⁃mediated
                                                                       tility disorders[J]. Int J Mol Sci,2022,23(13):6917
                    α⁃synuclein pathology:relevance to Parkinson’s disease[J].
                                                                 [18]DZAMKO N. Cytokine activity in Parkinson’s disease[J].
                    Cell Mol Life Sci,2023,80(6):166
                                                                       Neuronal Signal,2023,7(4):NS20220063
               [6] HOUSER M C,CAUDLE W M,CHANG J J,et al.
                                                                 [19]SHEN X N,HUANG S Y,CUI M,et al. Plasma glial fibril⁃
                    Experimental colitis promotes sustained,sex⁃dependent,  lary acidic protein in the Alzheimer disease continuum:
                    T ⁃ cell ⁃ associated neuroinflammation and Parkinsonian  relationship to other biomarkers,differential diagnosis,
                    neuropathology[J]. Acta Neuropathol Commun,2021,9  and prediction of clinical progression[J]. Clin Chem,
                   (1):139
                                                                       2023,69(4):411-421
               [7] MOKHTARE M,ALIMORADZADEH R,AGAH S,et al.
                                                                 [20]CHE N N,OU R W,LI C Y,et al. Plasma GFAP as a prog⁃
                    The  association  between  modulating  inflammatory
                                                                       nostic biomarker of motor subtype in early Parkinson’s
                    cytokines and constipation of geriatrics in Iran[J].
                                                                       disease[J]. NPJ Parkinsons Dis,2024,10(1):48
                    Middle East J Dig Dis,2017,9(4):228-234      [21]乙红艳,梁晓静,许富贵,等. 血浆胶质纤维酸性蛋白、
               [8] AGACHAN F,CHEN T,PFEIFER J,et al. A constipation    α⁃突触核蛋白水平与帕金森病病情进展的相关性[J].
                    scoring system to simplify evaluation and management of  中华行为医学与脑科学杂志,2023,32(11):999-1004
                    constipated patients[J]. Dis Colon Rectum,1996,39(6):  YI H Y,LIANG X J,XU F G,et al. Correlation between
   38   39   40   41   42   43   44   45   46   47   48